Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
type
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

1007853

	registered interest
	date	15/11/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Medical Treatments
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what progress has been made on creating a system whereby patient evidence can be considered as part of the specialised commissioning relative prioritisation process.
	tabling member constituency	Mansfield
	tabling member printed	Ben Bradley
	type	WrittenParliamentaryQuestion
	uin	191991
	answer	answer is ministerial correction date of answer 22/11/2018 answer text <p>Patients and the public already have the opportunity to submit peer reviewed, published evidence as part of the clinical commissioning policy and services specification development process and to comment on draft commissioning policies and service specifications during public consultation. An engagement report which summarises the views submitted is considered by the Clinical Priorities Advisory Group as part of their deliberations.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 22/11/2018 15:14:05 answering member 4067 label Biography information for Steve Brine
	tabling member	4663 label Biography information for Ben Bradley

1010780

	registered interest
	date	20/11/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Phenylketonuria
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what steps his Department is taking to help raise awareness of Phenylketonuria.
	tabling member constituency	Mansfield
	tabling member printed	Ben Bradley
	type	WrittenParliamentaryQuestion
	uin	193605
	answer	answer is ministerial correction date of answer 28/11/2018 answer text <p>The current new-born screening programme in the United Kingdom screens for nine rare but serious conditions including phenylketonuria (PKU). To recognise rare conditions such as PKU, doctors and other healthcare professionals are expected to ensure their clinical knowledge remains up-to-date and to identify their ongoing learning needs as part of their continuing professional development. This activity should include taking account of new research and developments in guidance in relevant specialty areas, such as those produced by the National Institute for Health and Care Excellence or the Royal Colleges, to ensure that they can continue to provide high quality care to all patients.</p><p> </p><p>Steps to increase the awareness of rare diseases such as PKU are being taken through the implementation of the UK Strategy for Rare Diseases. The Strategy includes commitments to improving the lives of all patients affected by rare diseases including in areas of identification/ prevention and diagnosis and early intervention. The Government is committed to implementing the Strategy’s commitments and in January 2018, the Department and NHS England published Implementation Plans setting out their actions for England.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 28/11/2018 17:39:49 answering member 4067 label Biography information for Steve Brine
	tabling member	4663 label Biography information for Ben Bradley

1017268

	registered interest
	date	29/11/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Diabetes: Nottinghamshire
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what estimate he has made of the number of people in Nottinghamshire who have diabetes.
	tabling member constituency	Mansfield
	tabling member printed	Ben Bradley
	type	WrittenParliamentaryQuestion
	uin	197472
	answer	answer is ministerial correction date of answer 07/12/2018 answer text <p>The information requested is not centrally held.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 07/12/2018 13:02:52 answering member 4067 label Biography information for Steve Brine
	tabling member	4663 label Biography information for Ben Bradley

1020406

	registered interest
	date	05/12/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	General Practitioners: Nottinghamshire
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, how many GP trainees began training in Nottinghamshire in 2017.
	tabling member constituency	Mansfield
	tabling member printed	Ben Bradley
	type	WrittenParliamentaryQuestion
	uin	199477
	answer	answer is ministerial correction date of answer 12/12/2018 answer text <p>There were 71 general practitioner (GP) trainees that began training in Nottinghamshire in 2017.</p><p> </p><p>The Targeted Enhanced Recruitment Scheme is a national incentive scheme which funds a £20,000 salary supplement to attract GP trainees to work in areas of the country where GP training places have been unfilled for a number of years. 144 places were available on the scheme in England in 2017, 11 of which were in Nottinghamshire.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 12/12/2018 14:56:49 answering member 4067 label Biography information for Steve Brine
	tabling member	4663 label Biography information for Ben Bradley

1027251

	registered interest
	date	17/12/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	General Practitioners: Nottinghamshire
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what steps his Department is taking to support the (a) recruitment and (b) retention of GPs in Nottinghamshire.
	tabling member constituency	Mansfield
	tabling member printed	Ben Bradley
	type	WrittenParliamentaryQuestion
	uin	202816
	answer	answer is ministerial correction date of answer 21/12/2018 answer text <p>NHS England and Health Education England (HEE) are working together with the profession to increase the general practitioner (GP) workforce nationally. This includes measures to boost recruitment, address the reasons why GPs are leaving the profession, and encourage GPs to return to practice.</p><p> </p><p>The Targeted Enhanced Recruitment Scheme is available in Nottinghamshire and offers a £20,000 salary supplement to attract doctors to parts of the country where there have been consistent shortages of GP trainees. 12 places were available in 2018 and a further 12 have been made available in 2019 in Sherwood Forest, Nottinghamshire.</p><p> </p><p>Mansfield and Ashfield Clinical Commissioning Group (CCG) and Newark and Sherwood CCG advise that the first wave of their international recruitment has taken place and the first few recruits are in post with further candidates in the pipeline. An increasing number of practices are also now sponsors for International Medical Graduates (on Tier 2 visas) who have trained in the United Kingdom.</p><p> </p><p>To address retention, the CCGs advise that they have a wide range of schemes available including a Trainee Transition programme which is providing trainees in their third year of training with flexible working options, a GP mentoring and support scheme, and a Post Certificate of Training (CCT) Fellowship. The CCT Fellowship provides additional support for GPs to extend their skills in leadership, digital working and urgent and emergency care.</p><p> </p><p>In additional to this, the CCGs advise that they are tackling practice workload and generating a wider culture of job satisfaction through engagement in the Releasing Time for Care programme. The programme includes training for administrative staff to reduce the burden on GPs.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 21/12/2018 14:21:48 answering member 4067 label Biography information for Steve Brine
	tabling member	4663 label Biography information for Ben Bradley

1027252

	registered interest
	date	17/12/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Dentistry: Nottinghamshire
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what steps his Department is taking to support the (a) recruitment and (b) retention of dentists in Nottinghamshire.
	tabling member constituency	Mansfield
	tabling member printed	Ben Bradley
	type	WrittenParliamentaryQuestion
	uin	202817
	answer	answer is ministerial correction date of answer 21/12/2018 answer text <p>Nationally, the number of dentists remain high. The latest data published in NHS Digital’s annual report on 30 August 2018 shows that 24,308 dentists delivered National Health Service dental services in 2017/18, 30 more than in 2016-17. The data is available at the following link:</p><p> </p><p><a href="https://digital.nhs.uk/data-and-information/publications/statistical/nhs-dental-statistics/2017-18-annual-report" target="_blank">https://digital.nhs.uk/data-and-information/publications/statistical/nhs-dental-statistics/2017-18-annual-report</a></p><p> </p><p>We are aware that the same figures show there has been a small fall in the total numbers of dentists working on NHS contracts. NHS England commissions primary care dental services and is responsible for ensuring there are sufficient dental services to meet local need. NHS England is closely monitoring any local difficulties in recruitment and retention and over the summer held a workshop with various dental stakeholders to identify the causes and potential actions.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 21/12/2018 14:11:42 answering member 4067 label Biography information for Steve Brine
	tabling member	4663 label Biography information for Ben Bradley

1078546

	registered interest
	date	27/02/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Fibromyalgia
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what steps his Department is taking to support people with fibromyalgia.
	tabling member constituency	Mansfield
	tabling member printed	Ben Bradley
	type	WrittenParliamentaryQuestion
	uin	226750
	answer	answer is ministerial correction date of answer 07/03/2019 answer text <p>The Department is committed to making sure people with long term conditions receive the personalised care and support they need.</p><p> </p><p>As set out in the NHS Long Term Plan, published on 7 January 2019, NHS England is taking action in range of areas to improve the care treatment and support provided to people with neurological conditions including rolling out the NHS Comprehensive Model of Personalised Care across the country, reaching 2.5 million people by 2023/24.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 07/03/2019 16:40:00 answering member 4067 label Biography information for Steve Brine
	tabling member	4663 label Biography information for Ben Bradley

1083523

	registered interest
	date	07/03/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Smoking: Health Services
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, with reference to the NHS rollout of lung cancer scanning programmes, what assessment he has made of the effectiveness of smoking cessation methods.
	tabling member constituency	Mansfield
	tabling member printed	Ben Bradley
	type	WrittenParliamentaryQuestion
	uin	229719
	answer	answer is ministerial correction date of answer 15/03/2019 answer text <p>The evidence is clear that expert face-to-face support from a local stop smoking service, combined with stop smoking aids, is the most effective quitting method. People who get this support are up to four times as likely to stop smoking successfully as those who try to quit unaided. This evidence can be viewed at the following link:</p><p> </p><p><a href="http://www.ncsct.co.uk/publication_Stop_smoking_services_impact_on_quitting.php" target="_blank">http://www.ncsct.co.uk/publication_Stop_smoking_services_impact_on_quitting.php</a></p><p> </p><p>Local authorities in England are responsible for commissioning stop smoking services that meet the identified need in their areas and are targeted at the people who need it most.</p><p> </p><p>NHS England published the Standard Protocol for the Targeted Lung Health Check programme which says participants will be asked about their smoking habits when they attend a lung health check, and offered smoking cessation advice and treatment. This programme can be viewed at the following link:</p><p> </p><p><a href="https://www.england.nhs.uk/publication/targeted-screening-for-lung-cancer/" target="_blank">https://www.england.nhs.uk/publication/targeted-screening-for-lung-cancer/</a></p> answering member constituency Winchester answering member printed Steve Brine question first answered 15/03/2019 12:27:55 answering member 4067 label Biography information for Steve Brine
	tabling member	4663 label Biography information for Ben Bradley

780496

	registered interest
	date	30/10/2017
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Human Papillomavirus: Vaccination
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, how many Yellow Cards submitted to the Medicines and Healthcare Products Regulatory Agency on the HPV vaccination have been classified as serious in the last three years.
	tabling member constituency	Mansfield
	tabling member printed	Ben Bradley
	type	WrittenParliamentaryQuestion
	uin	110248
	answer	answer is ministerial correction date of answer 07/11/2017 answer text <p>The Medicines and Healthcare products Regulatory Agency (MHRA) encourages anyone to report a suspected adverse reaction (ADR) to a vaccine or medicine through the Yellow Card Scheme:</p><p> </p><p><a href="http://www.mhra.gov.uk/yellowcard" target="_blank">www.mhra.gov.uk/yellowcard</a></p><p>A Yellow Card report is not proof of a side effect occurring, but a suspicion by the reporter that the vaccine or medicine may have been the cause. Such reports are kept under continual review to identify potential new risks.</p><p> </p><p>Between 31 October 2014 – 30 October 2017 a total of 649 serious suspected adverse reaction (ADR) reports with human papilloma virus (HPV) vaccines have been reported to the Medicines and Healthcare products Regulatory Agency (MHRA) via the Yellow Card Scheme (data run date: 1 November 2017). In this three year period, at least 1 million doses of HPV vaccine were administered in the United Kingdom.</p><p> </p><p>A breakdown of UK serious suspected spontaneous ADR reports received via the Yellow Card Scheme beween 31 October 2014 – 30 October 2016 by brand and year received is shown in the following table.</p><p> </p><table><tbody><tr><td><p>HPV Vaccine</p></td><td><p>Number of serious reports</p></td></tr><tr><td><p>HPV brand unspecified</p></td><td><p>181</p></td></tr><tr><td><p>Cervarix</p></td><td><p>64</p></td></tr><tr><td><p>Gardasil</p></td><td><p>390</p></td></tr><tr><td><p>Gardasil 9</p></td><td><p>18</p></td></tr><tr><td><p>Total</p></td><td><p>649</p></td></tr></tbody></table><p> </p><p>Source: MHRA sentinel database for adverse reactions</p><p> </p><p>Notes:</p><p> </p><p>The total number of reports received by vaccine brand is not equal to the totals in the table above as some reports included more than one HPV vaccine brand.</p><p> </p><p>The MHRA has received a total of 3,159 serious suspected adverse reaction reports associated with HPV vaccine (data run date 1 November 2017).</p><p> </p><p>All serious reports received via the Yellow Card Scheme are reviewed based on the details received from the reporter. Follow up letters may be sent for missing information such as vaccine brand name, batch number, medical history, results of investigations, diagnoses and details of outcome.</p><p> </p><p>The Commission on Human Medicines has thoroughly reviewed the safety of HPV vaccines and concluded that the evidence does not support a link between HPV vaccination and the development of chronic illnesses.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 110360 question first answered 07/11/2017 11:31:40 answering member 4067 label Biography information for Steve Brine
	tabling member	4663 label Biography information for Ben Bradley

780519

	registered interest
	date	30/10/2017
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Human Papillomavirus: Vaccination
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, how many Yellow Cards submitted to the Medicines and Healthcare Products Regulatory Agency for the HPV vaccination were classified as serious; and how many of those cases were reviewed to establish whether the patient had returned to full health in each of the last 12 months.
	tabling member constituency	Mansfield
	tabling member printed	Ben Bradley
	type	WrittenParliamentaryQuestion
	uin	110360
	answer	answer is ministerial correction date of answer 07/11/2017 answer text <p>The Medicines and Healthcare products Regulatory Agency (MHRA) encourages anyone to report a suspected adverse reaction (ADR) to a vaccine or medicine through the Yellow Card Scheme:</p><p> </p><p><a href="http://www.mhra.gov.uk/yellowcard" target="_blank">www.mhra.gov.uk/yellowcard</a></p><p>A Yellow Card report is not proof of a side effect occurring, but a suspicion by the reporter that the vaccine or medicine may have been the cause. Such reports are kept under continual review to identify potential new risks.</p><p> </p><p>Between 31 October 2014 – 30 October 2017 a total of 649 serious suspected adverse reaction (ADR) reports with human papilloma virus (HPV) vaccines have been reported to the Medicines and Healthcare products Regulatory Agency (MHRA) via the Yellow Card Scheme (data run date: 1 November 2017). In this three year period, at least 1 million doses of HPV vaccine were administered in the United Kingdom.</p><p> </p><p>A breakdown of UK serious suspected spontaneous ADR reports received via the Yellow Card Scheme beween 31 October 2014 – 30 October 2016 by brand and year received is shown in the following table.</p><p> </p><table><tbody><tr><td><p>HPV Vaccine</p></td><td><p>Number of serious reports</p></td></tr><tr><td><p>HPV brand unspecified</p></td><td><p>181</p></td></tr><tr><td><p>Cervarix</p></td><td><p>64</p></td></tr><tr><td><p>Gardasil</p></td><td><p>390</p></td></tr><tr><td><p>Gardasil 9</p></td><td><p>18</p></td></tr><tr><td><p>Total</p></td><td><p>649</p></td></tr></tbody></table><p> </p><p>Source: MHRA sentinel database for adverse reactions</p><p> </p><p>Notes:</p><p> </p><p>The total number of reports received by vaccine brand is not equal to the totals in the table above as some reports included more than one HPV vaccine brand.</p><p> </p><p>The MHRA has received a total of 3,159 serious suspected adverse reaction reports associated with HPV vaccine (data run date 1 November 2017).</p><p> </p><p>All serious reports received via the Yellow Card Scheme are reviewed based on the details received from the reporter. Follow up letters may be sent for missing information such as vaccine brand name, batch number, medical history, results of investigations, diagnoses and details of outcome.</p><p> </p><p>The Commission on Human Medicines has thoroughly reviewed the safety of HPV vaccines and concluded that the evidence does not support a link between HPV vaccination and the development of chronic illnesses.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 110248 question first answered 07/11/2017 11:31:40 answering member 4067 label Biography information for Steve Brine
	tabling member	4663 label Biography information for Ben Bradley